Spineart announce FDA 510(k) clearance to market the SCARLET AC-Ti secured anterior cervical cage.
SCARLET AC-Ti builds on a decade of experience with the SCARLET system. SCARLET AC-Ti introduces new features such as the MIMETIX morphometric profile, developed with digital models of the vertebrae to optimize the contact surface between implant and endplates. The system allows for fixation with screws and anchors.
The SCARLET AC-Ti cervical cage utilizes Spineart’s proprietary Ti-LIFE technology, a proprietary additive manufacturing process, with a porous structure that closely mimics the trabecular bone structure.
“This approval underscores our commitment to innovation, continuously evolving our most successful products, such as the SCARLET system,” said Alessia Erlingher, Chief Commercial Officer at Spineart.
Spineart announce FDA 510(k) clearance to market the SCARLET AC-Ti secured anterior cervical cage.
SCARLET AC-Ti builds on a decade of experience with the SCARLET system. SCARLET AC-Ti introduces new features such as the MIMETIX morphometric profile, developed with digital models of the vertebrae to optimize the contact surface between implant...
Spineart announce FDA 510(k) clearance to market the SCARLET AC-Ti secured anterior cervical cage.
SCARLET AC-Ti builds on a decade of experience with the SCARLET system. SCARLET AC-Ti introduces new features such as the MIMETIX morphometric profile, developed with digital models of the vertebrae to optimize the contact surface between implant and endplates. The system allows for fixation with screws and anchors.
The SCARLET AC-Ti cervical cage utilizes Spineart’s proprietary Ti-LIFE technology, a proprietary additive manufacturing process, with a porous structure that closely mimics the trabecular bone structure.
“This approval underscores our commitment to innovation, continuously evolving our most successful products, such as the SCARLET system,” said Alessia Erlingher, Chief Commercial Officer at Spineart.
Copy to clipboard 
